A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generation of Human CD40-activated B cells

15.1K views

⸱

DOI:

10.3791/1373

⸱

October 16th, 2009

 ,  ,  ,  , 

In This Article

Summary

In this video we present the ex vivo generation and expansion of human CD40-activated B cells (CD40-B) from peripheral blood mononuclear cells (PBMC) by stimulation with CD40 ligand and interleukin-4.

Abstract

CD40-activated B cells (CD40-B cells) have been identified as an alternative source of immuno-stimulatory antigen-presenting cells (APC) for cancer immunotherapy 1-3. Compared to Dendritic cells (DCs), the best characterized APC, CD40-B cells have several distinct biological and technical properties. Similar to DCs, B cells show an increased expression of MHC and co-stimulatory molecules (Fig.1b), exhibit a strong migratory capacity and present antigen presentation efficiently to T cells, after stimulation with interleukin-4 and CD40 ligand (CD40L). However, in contrast to immature or mature DCs, CD40-B cells express the full lymph node homing triad consisting of CD62L, CCR7/CXCR4, and leukocyte function antigen-1 (LFA1, CD11a/CD18), necessary for homing to secondary lymphoid organs (Fig.1a) 3. CD40-B cells can be generated without difficulties from very small amounts of peripheral blood which can be further expanded in vitro to very large amounts of highly-pure CD40-B cells (>109 cells per patient) from healthy donors as well as cancer patients (Fig.1c,d) 1,4.

In this protocol we demonstrate how to obtain fully activated CD40-B cells from human PBMC. Key molecules for the cell culture are CD40 ligand, interleukin-4 (IL-4) and cyclosporin A (CsA), which are replenished in a 3-4 day culture cycle. For laboratory purposes CD40-stimulation is provided by NIH/3T3 cells expressing recombinant human CD40 ligand (tCD40L NIH/3T3) 5. To avoid contamination with non-transfected cells, expression of the human CD40 ligand on the transfectants has to be checked regularly (Fig.2).

After 14 days CD40-B cell cultures consist of more than 95% pure B cells and an expansion of CD40-B cells over 65 days is frequently possible without any loss of function 1, 4. CD40-B cells efficiently take up, process and present antigens to T cells 6. They do not only prime naϊve, but also expand memory T cells 7,8. CD40-activated B cells can be used to study B-cell activation, differentiation and function. Moreover, they represent a promising tool for therapeutic or preventive vaccination against tumors 9.

Protocol

The protocol for the generation of human CD40-activated B cells from PBMC is divided into two parts: Part A demonstrates the preparation of CD40 ligand expressing NIH/3T3 cells, which will be used as plate-bound feeder cells. Part B describes the actual CD40-B culture.

A. Preparation of feeder cells (tCD40L NIH/3T3)

The tCD40L NIH/3T3 is an adherent murine fibroblast cell line, which should never become completely confluent. The cells are therefore splitted twice per week. Culturing over more than 6 weeks is not recommended.

  1. Remove old medium from the primary culture with a sterile pipette and wash c....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
A. Preparation of Media:
1. Feeder cell wild type medium
DMEM-Ham’s / F12
L-Glutamine (365 μg/mL)
FBS (10%)
HEPES (10 mM)
Gentamycin (15 μg/mL)
2. Feeder cell selection medium
DMEM-Ham’s / F12
L-Glutamine (365 μg/mL)
FBS (10%)
HEPES (10 mM)
Gentamycin (15 μg/mL)
G-418 (0.7 mg/mL)
3. CD40-B washing medium
IMDM
L-Glutamine (584 μg/mL)
HEPES (25 mM)
Gentamycin (15 μg/mL)
4. CD40-B culture medium
IMDM
L-Glutamine (584 μg/mL)
HEPES (25 mM)
Gentamycin (15 μg/mL)
rh Transferrin (50 μg/mL)
rh Insulin (5 μg/mL)
AB-Humanserum (10%)
B. Miscellaneous Reagents:
DMEM / Ham’s F12PAA LaboratoriesCat No: E15-813
IMDMInvitrogenREF 21980-032
Dulbecco’s PBS (10x)PAA LaboratoriesCat No H15-011
AB-Human SerumInvitrogenCat No 34005100
holo-Transferrin humanSigma-AldrichCat No T0665
Insulin humanSigma-AldrichCat No I2643
Gencin®Delta SelectArt No 7395800
Recombinant Human Interleukin-4ImmunotoolsCat No 11130045
Cyclosporin ANovartis AGCat No NDC 0078-0109-01
FBSLonza Inc.Cat No DE14-802C
HEPES BufferPAA LaboratoriesCat No S11-001
G-418 SulphatePAA LaboratoriesCat No P02-012
Trypsin/EDTA (10x)InvitrogenREF 15400-054
C. Miscellaneous Supplies:
Sterile pipette tipsSarstedt Ltd
6-well plateNalge Nunc internationalCat No 140675
50mL conical tubeBD BiosciencesCat No 352070
Tissue culture flaskSarstedt LtdCat No 83.1813.002

References

  1. Schultze, J. L. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest. 100, 2757-2765 (1997).
  2. Schultze, J. L., Grabbe, S., vonBergwelt-Baildon, M. S.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Peripheral Blood Mononuclear CellsCD40 LigandInterleukin-4Cyclosporine ANIH/3T3 CellsFeeder Cell PreparationCell Culture ExpansionAntigen PresentationLymph Node Homing